Avicanna and Medipharm Labs Expand Strategic Manufacturing Agreement for Avicanna’s Proprietary SEDDS Technology Capsules for Canadian and International markets
June 26, 2023 07:30 ET
|
Avicanna Inc.
Avicanna’s proprietary SEDDS technology capsules are designed for enhanced and rapid absorption of cannabinoids. Avicanna and Medipharm intend to commercialize various formulations of Avicanna’s...
Avicanna Sponsors New Medical Cannabis Education and Training Campaign in Canada with the Canadian Consortium for the Investigation of Cannabinoids (“CCIC”)
June 22, 2023 07:30 ET
|
Avicanna Inc.
TORONTO, June 22, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on...
Avicanna and Langara College Announce Cannabinoid-Based Translational Research Collaboration and NSERC Grant
June 13, 2023 07:30 ET
|
Avicanna Inc.
This Research Collaboration will be led by Dr. Jessica Kalra’s research team and focus on characterization of Avicanna’s proprietary products and drug pipeline formulations This Research...
Shoppers Drug Mart and Avicanna Execute Definitive Asset Purchase Agreement for Avicanna’s Acquisition of the Medical Cannabis by Shoppers Business
May 29, 2023 07:30 ET
|
Avicanna Inc.
TORONTO, May 29, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and...
Avicanna Announces Results of Annual General and Special Meeting and Provides Corporate Update
May 17, 2023 17:30 ET
|
Avicanna Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
Avicanna Reports Q1 2023 Financial Statement
May 16, 2023 07:30 ET
|
Avicanna Inc.
TORONTO, May 16, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing,...
Avicanna and Northern Green Canada Execute Master Service Agreement to Operationalize MyMedi.ca
May 04, 2023 07:30 ET
|
Avicanna Inc.
MyMedi.ca to provide Medical Cannabis by Shoppers patients a complete medical cannabis care platform including curated products and services. NGC will facilitate inventory management and fulfillment...
Avicanna Announces Filing of Annual Financial Statements for Year Ended December 31, 2022
April 03, 2023 07:30 ET
|
Avicanna Inc.
92% Y-Y increase in Canadian product sales, driven by increased number of commercial SKUs and listings. $4M in revenue, representing 24% Y-Y growth coupled with reduction in SG&A and 35% in EBITA...
Shoppers Drug Mart partners with Avicanna to transition Medical Cannabis by Shoppers
March 28, 2023 07:50 ET
|
Avicanna Inc.
TORONTO, March 28, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and...
Avicanna Announces Closing of Non-Brokered Private Placement
March 21, 2023 07:30 ET
|
Avicanna Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...